
|Podcasts|December 23, 2020
Comparing micro-bypass implant + phaco vs phaco in POAG
Author(s)David Hutton, Alex Delaney-Gesing
Thomas Samuelson, MD, speaks on the outcomes of a three-year trial analyzing the iStent inject trabecular micro-bypass + phaco versus phaco alone in patients with POAG.
Advertisement
During AAO 2020, Thomas Samuelson, MD, speaks on the outcomes of a three-year trial analyzing the iStent inject trabecular micro-bypass + phaco versus phaco alone in patients with POAG.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Evolving glaucoma therapy: A new era of interventional strategies
2
ICYMI: AAO 2025 showcases new technologies and continued research
3
Precision strategy: Optimizing visual outcomes with advanced small-aperture lenses
4
Q&A: William F. Wiley, MD, on what BVI's trifocal IOL approval means for US premium vision options
5

















































.png)


